clindamycin

(redirected from Evoclin)
Also found in: Medical.

Related to Evoclin: Cleocin T

clin·da·my·cin

(klĭn′də-mī′sĭn)

A semisynthetic antibiotic, C₁₈H₃₃ClN₂O₅S, derived from lincomycin and active against gram-positive bacteria.

[Alteration and blend of chloro- and lincomycin (with d perhaps from deoxy-).]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

clindamycin

(ˌklɪndəˈmaɪsɪn)

(Medicine) an antibiotic used to treat bacterial infections

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

Translations

clindamycin

n clindamicina

References in periodicals archive ?

The GlaxoSmithKline and Stiefel products include Evoclin Foam, Extina Foam, Luxiq Foam, Olux Foam, Olux-E Foam, Vusion Ointment, Zovirax Capsules, Zovirax Tablets and Zovirax Suspension.

Renaissance acquires rights for nine products from GlaxoSmithKline

A recent treatment option for acne of the trunk is clindamycin phosphate 1% (Evoclin Foam, Connetics Corp).

Assess vulgaris patients for lesions on trunk

Clindamycin phosphate foam 1% (Evoclin Foam, Connetics Corp.) is approved for topical treatment of acne vulgaris in patients aged 12 years and older.

Once-daily clindamycin foam easier for patients

The products from GSK and Stiefel, a GSK company, which will be marketed through Renaissance's branded division Prestium Pharma, include Evoclin (clindamycin phosphate) Foam 1%; Extina (ketoconazole) Foam 2%; Luxiq (betamethasone valerate) Foam 0.12% ; Olux (clobetasol propionate) Foam 0.05% ; Olux-E (clobetasol propionate) Foam 0.05%; Vusion (miconazole nitrate 0.25%, zinc oxide 15% and white petrolatum 81.35%) Ointment; Zovirax (acyclovir) capsules; Zovirax (acyclovir) tablets and Zovirax (acyclovir) suspension.

Renaissance and GlaxoSmithKline sign agreement for transfer of nine products

have launched a generic version of Evoclin foam 1% (clindamycin phosphate foam 1%).

New options for patients hit market

The Food and Drug Administration approved Evoclin Foam, 1% for topical treatment of ache vulgaris in patients 12 years and older.